Electrophysiology Market is projected to expand at a steady CAGR of 8.9% during forecast period 2021-2031 | Abbott, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V.

The Electrophysiology Market was valued at USD 7.2 billion in 2021 and it is anticipated to reach up to USD 16.9 billion by 2031, at a CAGR of 8.9% during the forecast period.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample – https://www.globalinsightservices.com/request-sample/GIS10275

Atrial and ventricular fibrillation, tachycardia, and other diseases that have an impact on the heart are mostly diagnosed and treated with electrophysiology equipment. Healthcare professionals use a variety of tools based on the electrophysiological technique to identify and treat various disorders, including ablation and diagnostic catheters, mapping systems, etc.

Market Trends and Drivers

The increasing incidence of target diseases and procedures is boosting the growth of the market. According to the WHO, CVD is the largest global cause of death. Age, race, and family history are significant factors influencing the increased prevalence of CVD and strokes. Other risk factors include using tobacco, having high blood pressure (hypertension), having high cholesterol, being obese, being physically inactive, having diabetes, eating unhealthily, and drinking alcohol.

Get A Customized Scope to Match, Your Need Ask an Expert – https://www.globalinsightservices.com/request-customization/GIS10275

The prevalence of CVD is on the rise in part due to conditions like hypertension, diabetes, dyslipidemia, and obesity. By 2030, the American Heart Association projects that 41.4% of US individuals will have hypertension (an increase of 8.4 percent from 2012). Additionally, according to the organization, the cost of CVD will increase from USD 863 billion in 2010 to USD 1,044 billion by 2030. Globally, 17.9 million people passed away from CVD in 2016. According to projections, this number will reach 23.6 million by 2030.

The American Heart Association (AHA) claims that catheter-based ablation techniques have a 90% success rate, and minimal risk of complications, and allow patients to return to their regular activities in a few days. Leading businesses are investing more in the creation of novel cardiac ablation devices to increase success rates and decrease problems during procedures, including Biosense Webster, Medtronic, and Boston Scientific Corporation.

The limited effectiveness of anti-arrhythmic medications in the management of arterial filtration is another factor boosting catheter ablation demand. A study titled Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT 2) presented its findings in Massachusetts (US) in May 2012 at the Heart Rhythm Society meeting, concluding that ablation of AF, when used as a first-line method, was superior to medications that control rhythm.

For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/checkout/single_user/GIS10275

Market Segments

By Product Type

  • Electrophysiology Ablation Catheters
  • Electrophysiology Laboratory Devices
  • Electrophysiology Diagnostic Catheters
  • Electrophysiology Access Devices
  • Others

By Indication Type

  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Reentry Tachycardia
  • Wolf-Parkinson-White Syndrome
  • Others

By End Users

  • Hospitals & Cardiac Centers
  • Ambulatory Surgery Centers

Major Players in the Global Electrophysiology Market

The key players studied in the global electrophysiology market are Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthcare GmbH (Germany), Stereotaxis, Inc. (US), Merit Medical Systems (US), Atricure Inc. (US), APN Health, LLC (US), Osypka Medical (Germany), Japan LifeLine Co., Ltd. (Japan), Johnson & Johnson (US), Biotronik (Germany), MicroPort Scientific Corporation (China), Acutus Medical, Inc. (US), Lepu Medical Technology (Beijing), CathRx Ltd. (Australia), Cook Medical (US), CathVision ApS (Denmark), TZ Medical (US), Teleflex Incorporated (US), Imricor (US), CardioFocus (US), Schwarzer Cardiotek GmbH (Germany), Kardium (Canada), EP Solutions SA (Switzerland), BioSig Technologies Inc. (BSGM) (US), Coremap (US), and EPMap System GmbH (Germany).

New Report Published by Global Insight Services: https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/